Mind the Gap: Primary Prevention Aspirin and the Danger of Suboptimal Implementation of Contemporary Guidelines Into Clinical Practice-Reference-Cited by-同舟云学术

Mind the Gap: Primary Prevention Aspirin and the Danger of Suboptimal Implementation of Contemporary Guidelines Into Clinical Practice

Published:2022-03 Issue:3 Volume:15 Page:
ISSN:1941-7713
Container-title:Circulation: Cardiovascular Quality and Outcomes
language:en
Short-container-title:Circ: Cardiovascular Quality and Outcomes

Author:

Almagal Naeif¹²,Cainzos-Achirica Miguel³⁴^ORCID,McEvoy John W.²⁵^ORCID

Affiliation:

1. Prince Mohammed bin Abdulaziz Medical City, Ministry of Health, Saudi Arabia (N.A.).

2. Division of Cardiology, Department of Medicine, Saolta University Healthcare Group, University Hospital Galway, Ireland (N.A., J.W.M.).

3. Division of Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, TX (M.C.-A.).

4. Center for Outcomes Research, Houston Methodist, TX (M.C.-A.).

5. National Institute for Prevention and Cardiovascular Health, School of Medicine, National University of Ireland Galway (J.W.M.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference9 articles.

1. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

2. The rise and fall of aspirin in the primary prevention of cardiovascular disease

3. A Transatlantic Comparison of Patient-Reported Access to and Use of Aspirin in Contemporary Preventive Cardiology

4. Aspirin for cardiovascular disease prevention among adults in the United States: Trends, prevalence, and participant characteristics associated with use

5. Potential Impact of the 2019 American College of Cardiology/American Heart Association Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended Indication for Primary Prevention of Cardiovascular Disease in Cardiology Practices: Insights From the National Cardiovascular Disease Registry Practice Innovation and Clinical Excellence Registry.;Hira RS;Circ Cardiovasc Qual Outcomes,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does Stopping Aspirin Differ Fundamentally From Not Starting Aspirin in the Primary Prevention of Cardiovascular Disease Among Older Adults?;Annals of Internal Medicine;2022-05